XML 33 R19.htm IDEA: XBRL DOCUMENT
v3.22.2

Share-Based Compensation Plans | 6 Months Ended
--- | ---
Jun. 30, 2022
Share-based Payment Arrangement [Abstract] |
Share-Based Compensation Plans | Share-Based Compensation Plans Share-based compensation expense was $9 million and $18 million during the three and six months ended June 30, 2022, respectively, and $8 million and $17 million during the three and six months ended June 30, 2021, respectively. The unrecognized compensation expense related to our stock options, restricted stock units and performance share units was $9 million, $35 million and $17 million, respectively, at June 30, 2022 and is expected to be recognized over a weighted average period of 2.0, 2.1 and 2.4 years, respectively. The amount of cash received from the exercise of stock options was $3 million and $9 million for the six months ended June 30, 2022 and 2021, respectively. Stock Option Grants The following is a summary of the changes in outstanding stock options for the six months ended June 30, 2022:
| Share units (in thousands) |  | Weighted Average Exercise Price / Share |  | Weighted Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value (in millions)
Outstanding at January 1, 2022 | 1,827 |  |  | $ | 64.12 |  |  | 6.1 |  | 102
Granted | 306 |  |  | 86.76 |  |  |  |  |
Exercised | (58) |  |  | 48.07 |  |  |  |  |
Forfeited and expired | (20) |  |  | 90.49 |  |  |  |  |
Outstanding at June 30, 2022 | 2,055 |  |  | $ | 67.69 |  |  | 6.2 |  | $ | 32 |
Options exercisable at June 30, 2022 | 1,432 |  |  | $ | 59.14 |  |  | 5.1 |  | $ | 30 |
Vested and expected to vest as of June 30, 2022 | 1,980 |  |  | $ | 66.91 |  |  | 6.1 |  | $ | 31 |
The total intrinsic value of options exercised (which is the amount by which the stock price exceeded the exercise price of the options on the date of exercise) during the six months ended June 30, 2022 was $2.1 million. Stock Option Fair Value The fair value of each option grant was estimated on the date of grant using the binomial lattice pricing model which incorporates multiple and variable assumptions over time, including assumptions such as employee exercise patterns, stock price volatility and changes in dividends. The following are weighted-average assumptions for 2022 grants:
Volatility | 26.20 |  | %
Risk-free interest rate | 1.59 |  | %
Dividend yield | 1.38 |  | %
Expected term (in years) | 5.6 |
Weighted-average fair value / share | $ | 19.86 |  |
Expected volatility is calculated based on an analysis of historic volatility measures for Xylem. We use historical data to estimate option exercise and employee termination behavior within the valuation model. Employee groups and option characteristics are considered separately for valuation purposes. The expected term represents an estimate of the period of time options are expected to remain outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of option grant. Restricted Stock Unit Grants The following is a summary of restricted stock unit activity for the six months ended June 30, 2022. The fair value of the restricted share unit awards is determined using the closing price of our common stock on date of grant:
| Share units (in thousands) |  | Weighted Average Grant Date Fair Value / Share
Outstanding at January 1, 2022 | 484 |  |  | $ | 88.47 |
Granted | 323 |  |  | 86.42 |
Vested | (215) |  |  | 84.40 |
Forfeited | (26) |  |  | 91.34 |
Outstanding at June 30, 2022 | 566 |  |  | $ | 88.72 |
ROIC Performance Share Unit Grants The following is a summary of Return on Invested Capital ("ROIC") performance share unit grants for the six months ended June 30, 2022. The fair value of the ROIC performance share units is equal to the closing share price on the date of the grant:
| Share units (in thousands) |  |  |  |  |  | Weighted Average Grant Date Fair Value / Share
Outstanding at January 1, 2022 | 177 |  |  |  |  |  |  | $ | 84.84 |
Granted | 35 |  |  |  |  |  |  | 86.76 |
Forfeited (a) | (59) |  |  |  |  |  |  | 75.49 |
Outstanding at June 30, 2022 | 153 |  |  |  |  |  |  | $ | 88.89 |
(a) Includes ROIC performance share unit awards forfeited during the period as a result of the final performance condition not being achieved on vest date. TSR Performance Share Unit Grants The following is a summary of our Total Shareholder Return ("TSR") performance share unit grants for the six months ended June 30, 2022:
| Share units (in thousands) |  |  |  |  |  | Weighted Average Grant Date Fair Value / Share
Outstanding at January 1, 2022 | 177 |  |  |  |  |  |  | $ | 102.96 |
Granted | 70 |  |  |  |  |  |  | 71.14 |
Adjustment for Market Condition Achieved (a) | 22 |  |  |  |  |  |  | 89.62 |
Vested | (75) |  |  |  |  |  |  | 89.62 |
Forfeited | (7) |  |  |  |  |  |  | 87.54 |
Outstanding at June 30, 2022 | 187 |  |  |  |  |  |  | $ | 100.64 |
(a) Represents an increase in the number of original TSR performance share units awarded based on the final market condition achievement at the end of the performance period of such awards. The fair value of TSR performance share units was calculated on the date of grant using a Monte Carlo simulation model utilizing several key assumptions, including expected Company and peer company share price volatility, correlation coefficients between peers, the risk-free rate of return, the expected dividend yield and other award design features. The following are weighted-average assumptions for 2022 grants:
Volatility | 33.3 |  | %
Risk-free interest rate | 1.44 |  | %
Revenue Performance Share Unit Grants The following is a summary of our Revenue performance share unit grants for the six months ended June 30, 2022:
| Share units (in thousands) |  |  |  |  |  | Weighted Average Grant Date Fair Value / Share
Outstanding at January 1, 2022 | — |  |  |  |  |  |  | $ | — |
Granted | 35 |  |  |  |  |  |  | 86.76 |
Forfeited | (1) |  |  |  |  |  |  | 86.76 |
Outstanding at June 30, 2022 | 34 |  |  |  |  |  |  | $ | 86.76 |
The fair value of the Revenue performance share unit awards is determined using the closing price of our common stock on date of grant. The shares will vest contingent upon the achievement of a pre-set, three-year Revenue target.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration